---
category: news
title: "AI Integration In Biotech & Pharma: Companies Positioned To Benefit"
excerpt: "From optimizing clinical trial design to analyzing vast datasets for potential drug candidates, Novartis sees AI as instrumental in advancing its research. Roche's (OTC:RHHBY) interest in AI isn't just theoretical. They've acquired several companies and ..."
publishedDateTime: 2023-09-11T17:41:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/ai-integration-in-biotech-pharma-companies-positioned-to-benefit-1032621068"
webUrl: "https://markets.businessinsider.com/news/stocks/ai-integration-in-biotech-pharma-companies-positioned-to-benefit-1032621068"
type: article
quality: 69
heat: 69
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - Facebook AI
  - AI

images:
  - url: "https://cdn.benzinga.com/files/imagecache/1024x768xUP/national-cancer-institute-xknubmnjbkg-unsplash_1.jpg"
    width: 1024
    height: 768
    isCached: true

secured: "YZP8s9SDZ6R1o3cFmJ/3jc0QX+E0+U2pBbT0mDzc9nH4LigXR04q8VuYnSEbrlQIpL8Rs6kzPQd5xmifiyKfEh4fbFk5kXzYxF52tQJSjVpmebji01ywhpZY/6PffNSChImrIvybJEBc9U3CDV6McxozeicHf7p2o3qiGTcNua0cTlIQOvA2IgUlPc1yqng+q8NzBTpC9kJNGRhx6wmXtkJn8KP7w0BOJBrdJDoXfb6Wq4oKBV3fUeTurkHlz40lCi4aaNRflgvANMMiW0DLIiZqsM3Okrft/rjfw0q48Br1Gea4G1QDjTgMvUiSRooncXGyGpxb3N4QcUydC8lcZmI2qXuqu93dtbK8pWMzu7s=;YTwti/LMxby36MzZSamlVQ=="
---

